Relative dose intensity in early stage breast cancer chemotherapy: A retrospective analysis of incidence, risk factors and outcomes at a south-west Sydney cancer clinic-Reference-Cited by-同舟云学术

Relative dose intensity in early stage breast cancer chemotherapy: A retrospective analysis of incidence, risk factors and outcomes at a south-west Sydney cancer clinic

Published:2013-08-12 Issue:4 Volume:9 Page:365-372
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Sandy Jessica¹,Della-Fiorentina Stephen¹

Affiliation:

1. Macarthur Cancer Therapy Centre; Campbelltown New South Wales Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12093/fullpdf

Reference26 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials;Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Lancet,2005

2. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer;Budman;J Natl Cancer Inst,1998

3. Chemotherapy dose intensity determination as a quality of care measurement for managed care organisations in the treatment of early-stage breast cancer;Morrow;Am J Med Qual,2002

4. Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma;Wildiers;Crit Rev Oncol Hemtaol,2011

5. The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned?;Piccart;Eur J Cancer,2000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer;JAMA Oncology;2020-02-01

2. Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity;Journal of Cancer Education;2019-08-08

3. CYP2J2∗7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients;Frontiers in Pharmacology;2019-05-14

4. Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer;Clinical Breast Cancer;2018-10

5. Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer;Breast Cancer Research;2017-08-29